Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PLXDC2 inhibitors(plexin domain containing 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis | Preclinical | US | 24 Jan 2024 |